Corcept Therapeutics Incorporated (CORT)

Corcept Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,547	5,280	3,348	2,186	2,097	3,039
Market Cap Growth	362.13%	57.69%	53.13%	4.24%	-30.98%	119.78%
Enterprise Value	6,980	4,739	2,933	1,787	1,603	2,598
Last Close Price	70.59	50.39	32.48	20.31	19.80	26.16
PE Ratio	62.19	37.78	31.74	21.59	18.64	28.67
Forward PE	49.86	32.11	32.61	19.95	21.01	32.91
PS Ratio	10.67	7.82	6.94	5.44	5.73	8.59
PB Ratio	10.95	7.77	6.61	4.36	5.58	5.81
P/TBV Ratio	11.04	7.77	6.61	4.36	5.58	5.81
P/FCF Ratio	42.58	26.95	26.38	18.23	12.53	20.16
P/OCF Ratio	42.04	26.66	26.36	18.17	12.49	20.00
PEG Ratio	-	-	-	-	1.50	-
EV/Sales Ratio	10.18	7.02	6.08	4.45	4.38	7.34
EV/EBITDA Ratio	62.70	34.40	27.08	15.69	12.73	20.18
EV/EBIT Ratio	63.24	34.60	27.34	15.87	12.88	20.26
EV/FCF Ratio	39.40	24.19	23.12	14.90	9.58	17.24
Debt / Equity Ratio	0.01	0.01	0	0.00	0.00	0.01
Debt / EBITDA Ratio	0.06	0.05	0.00	0.01	0.00	0.02
Debt / FCF Ratio	0.04	0.04	0.00	0.01	0.00	0.02
Asset Turnover	0.91	0.92	0.80	0.80	0.74	0.72
Inventory Turnover	1.04	1.08	0.94	0.97	1.07	1.08
Quick Ratio	2.69	3.11	4.05	6.60	5.31	9.86
Current Ratio	3.07	3.35	4.39	6.89	5.61	10.07
Return on Equity (ROE)	21.77%	23.81%	21.05%	23.11%	25.03%	23.70%
Return on Assets (ROA)	9.18%	11.71%	11.13%	13.98%	15.63%	16.29%
Return on Capital (ROIC)	11.14%	14.34%	13.28%	16.01%	17.25%	17.79%
Return on Capital Employed (ROCE)	15.70%	19.60%	20.80%	22.00%	33.10%	24.50%
Earnings Yield	1.76%	2.67%	3.17%	4.64%	5.36%	3.49%
FCF Yield	2.35%	3.71%	3.79%	5.48%	7.98%	4.96%
Buyback Yield / Dilution	-5.07%	-1.55%	3.64%	7.94%	-1.42%	-1.33%

Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q